Labeled cells of renin lineage (CoRL) co-express nephrin in glomeruli of <i>Ren1cCre /R26R-ConfettiTG/WT</i> mice with experimental FSGS. by Natalya V. Kaverina (3854254)

Degradation of clots of different ages. by Jan Víteček (11434774)

DataSheet_1_Dectin-1 Controls TSLP-Induced Th2 Response by Regulating STAT3, STAT6, and p50-RelB Activities in Dendritic Cells.pdf by Chao Gu (402478)

“…Dectin-1 stimulation induced STAT3 activation and decreased the transcriptional activity of p50-RelB, both of which resulted in reduced OX40L expression on TSLP-activated mDCs. …”

A change-point–based control chart for detecting sparse mean changes in high-dimensional heteroscedastic data by Zezhong Wang (15138025)

Analysis of HspB1 and HspB5 phosphorylation. by Stéphanie Simon (75323)

“…Bb) Modulation of the phosphorylation of HspB1 and HspB5 by the R120G mutation. The R120G/WT ratio of the different HspB1 and HspB5 phosphoserine sites was defined as the ratio between the level of phosphorylation in R120G cells to that observed in WT cells. …”

Image_2_Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.jpeg by Jae Hong Choi (3339120)

“…Background<p>Effective vaccines against coronavirus disease 2019 (COVID-19) are available worldwide; however, the longevity of vaccine effectiveness is not known.</p>Objective<p>We performed a prospective observational study to assess the antibody response of healthcare workers against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after BNT162b2 mRNA COVID-19 vaccination.…”

Image_1_Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.jpg by Jae Hong Choi (3339120)

“…Background<p>Effective vaccines against coronavirus disease 2019 (COVID-19) are available worldwide; however, the longevity of vaccine effectiveness is not known.</p>Objective<p>We performed a prospective observational study to assess the antibody response of healthcare workers against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after BNT162b2 mRNA COVID-19 vaccination.…”

Time courses of normalized median frequency of inspiratory rib cage muscles. by Thiago Bezerra Wanderley e Lima (14232350)

Intracellular pH of <i>C</i>. <i>albicans</i> ATCC 90028; FLC-susceptible <i>C</i>. <i>albicans</i> D27and FLC-resistant <i>C</i>. <i>albicans</i> D15.9 with and without the treatm... by Mohammad Irfan (464459)

a) Number weighted mean volume of AEII during postnatal development and in adults.... by Julia Hüttmann (22656283)

“…<p>a) Number weighted mean volume of AEII during postnatal development and in adults. …”

The process of selecting participants. by Na Li (6550)

“…Chemotherapy was found to be protective factor for OS (HR = 0.33, 95%CI: 0.30–0.37)/CSS (HR = 0.44, 95%CI: 0.39–0.50) of ovarian cancer patients, while not receiving surgery remained a risk factor. …”

C-indexes for the nomograms. by Na Li (6550)

“…Chemotherapy was found to be protective factor for OS (HR = 0.33, 95%CI: 0.30–0.37)/CSS (HR = 0.44, 95%CI: 0.39–0.50) of ovarian cancer patients, while not receiving surgery remained a risk factor. …”

PRMT5 regulates alternative splicing landscape under hypoxia. by Srinivas Abhishek Mutnuru (22513457)

“…<b>H)</b> qRT-PCR showing an increase in exon 18A/18B ratio in shCTRL vs. shPRMT5 MCF7 and MDA-MB-231 cells under hypoxia. <b>I)</b> qRT-PCR showing a decrease in 18A/18B ratio upon PRMT5 OE in shPRMT5 MCF7 cells under hypoxia. …”

Length of whole blood clots from different amounts of blood in the in vitro middle cerebral artery model (diameter 3.1 mm). by Jan Víteček (11434774)

Fixed Peripapillary Thickness. by Harry A. Quigley (695817)

Experimental study groups and the number of animals within each. by Harry A. Quigley (695817)

Primary antibodies used for histological studies and Immunoblot. by Harry A. Quigley (695817)

Blood pressure data. by Harry A. Quigley (695817)

Axial length and width. by Harry A. Quigley (695817)

Inhibition of PRMT5 results in enhanced cell death and reduced growth of canine lymphoma cell lines and primary samples. by Shelby L. Sloan (10803222)

“…<p>(A) Representative flow cytometry plots of cell line 17–71 treated with the PRMT5 inhibitor (C220) for 5 days demonstrating staining for early (Annexin-V+/PI-) and late apoptotic (Annexin-V+/PI+) cells. …”